Capnopharm to acquire operational assets of Capnomed
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
This GMP and Pre-Approval Inspection is part of the routine business operations and the company shall submit to US FDA within the stipulated timeline
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Company is investing more than €100 million in the expansion of the Halle site
The company has received 2 observations on FDA Form 483 with respect to ANDA filed for the product to be manufactured at Indore plant.
Meets the growing need for US-based API solubility and bioavailability enhancement services
Subscribe To Our Newsletter & Stay Updated